Søg i kliniske forsøg efter: RLS-0071 (10 mg/kg intravenøst hver 8. time for i alt 3 doser)
I alt 15 resultater
-
ReAlta Life Sciences, Inc.FGK Clinical Research GmbHAfsluttet
-
Sheba Medical CenterUkendt
-
University Health Network, TorontoAktiv, ikke rekrutterendeAksial spondyloarthritisCanada
-
PfizerAfsluttet
-
Stanford UniversityWashington University School of Medicine; Duke University; University of... og andre samarbejdspartnereTilmelding efter invitationNasal obstruktion | Nasale kirurgiske procedurerForenede Stater
-
Gilead SciencesAfsluttetHepatitis CForenede Stater, Puerto Rico
-
Spanish Clinical Pharmacology SocietySpanish reumatology SocietyAfsluttet
-
Hospital for Special Surgery, New YorkAfsluttetTotal hofteudskiftningForenede Stater
-
Shaymaa Mohammed El-AwadyRekrutteringAllogen knoglemarvstransplantationEgypten
-
University of PittsburghGenentech, Inc.Afsluttet
-
Hellenic Oncology Research GroupAfsluttet
-
Royal Marsden NHS Foundation TrustHoffmann-La Roche; Professor Cunningham's Clinical Research FundAfsluttetKræft i bugspytkirtlenDet Forenede Kongerige
-
The First Affiliated Hospital with Nanjing Medical...Huai'an First People's Hospital; Yancheng First People's HospitalRekruttering
-
Medical University of ViennaPolymun Scientific, Vienna, AustriaAfsluttet
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeMetastatisk nyrecellekarcinom | Stadie III nyrecellekræft AJCC v8 | Stadie IV nyrecellekræft AJCC v8 | Metastatisk nyremarvkarcinom | SMARCB1 negativForenede Stater